History

As early as the 1920s, Erbe developed one of the first electrosurgical units for use in the operating room, playing a key role in shaping modern electrosurgery. In 1980, the company achieved another technological milestone with the launch of the Erbotom TUR, the world's first microprocessor-controlled electrosurgical unit.

Today, Erbe's technology portfolio includes electrosurgery, vessel sealing, argon plasma coagulation, hydro surgery and cryotechnology. Erbe systems and instruments are used worldwide in surgery and endoscopy, including gastroenterology, urology, gynecology and pulmonology.

As electrosurgical procedures became increasingly established around the world during the second half of the twentieth century, Erbe systematically expanded its international presence. What began with the export of medical systems gradually evolved into a global network of sales and service subsidiaries, followed by production and development sites.

This international expansion enables Erbe to provide customers around the world with closer support, faster technical service and comprehensive training while responding more effectively to regional market requirements. With operations in more than 20 countries, the company can react quickly to medical advances, regulatory developments and emerging technology trends.

Today, Erbe's international locations work closely with the headquarters in Tübingen, forming a global network for research and development, manufacturing, sales and service.

What began with the inventive spirit of a skilled craftsman has grown into a globally connected innovation network built on research, fundamental development and close collaboration.

For more than 175 years, Erbe has been shaping medical technology—from the early days of electrosurgery to today's intelligent, connected system solutions for clinical practice.

At Erbe, innovation goes far beyond individual inventions. It is driven by continuous dialogue with healthcare professionals and close cooperation with universities and research institutions around the world. Sustained investment in research and fundamental development—consistently above the industry average—provides the foundation for this progress.

Because innovation does not happen by chance. It is the result of inquisitiveness, commitment, collaboration and a shared responsibility to continuously improve patient care.

In 2025, Erbe began realigning its global organization with a clear objective: to strengthen customer centricity and transparency across all regions. By bringing our organization closer to our customers and establishing clearer structures and responsibilities, we aim to better understand local market needs, foster collaboration, and provide more effective support worldwide.

Our global organization is structured into four major regions:

• North America
• Latin America
• Asia Pacific
• Europe, Middle East & Africa

This new structure strengthens the Erbe Group's international presence and creates the foundation for continued global growth.

At the same time, the Erbe Group is further expanding its global footprint by strengthening production, research and development, service, and logistics capabilities across multiple countries, increasing resilience and reducing risk throughout its value chain.

In addition, the Group is broadening its technology portfolio by expanding its Optical Technologies division and establishing a dedicated competence center to drive future innovation and growth in this field.